ANO4
Basic information
Region (hg38): 12:100717526-101128641
Previous symbols: [ "TMEM16D" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Early infantile epileptic encephalopathy with suppression bursts (5 variants)
- Generalized epilepsy with febrile seizures plus (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANO4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 26 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 6 | 0 | 26 | 1 | 1 |
Variants in ANO4
This is a list of pathogenic ClinVar variants found in the ANO4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-100939380-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
12-100939407-A-C | not specified | Uncertain significance (Dec 13, 2022) | ||
12-100942399-C-T | not specified | Uncertain significance (Dec 27, 2022) | ||
12-100942462-C-A | not specified | Uncertain significance (Jan 04, 2022) | ||
12-100942466-C-G | Early infantile epileptic encephalopathy with suppression bursts | Pathogenic (Mar 26, 2024) | ||
12-100971327-A-G | not specified | Uncertain significance (Oct 05, 2021) | ||
12-100987663-A-T | not specified | Uncertain significance (Apr 08, 2024) | ||
12-101020074-A-T | not specified | Uncertain significance (Jan 30, 2024) | ||
12-101037115-A-G | not specified | Uncertain significance (Feb 27, 2023) | ||
12-101040034-C-G | not specified | Uncertain significance (Feb 27, 2024) | ||
12-101042440-G-A | Likely benign (Jul 10, 2018) | |||
12-101042447-C-G | not specified | Uncertain significance (Mar 19, 2024) | ||
12-101043542-A-T | not specified | Uncertain significance (Mar 31, 2023) | ||
12-101043631-C-G | not specified | Uncertain significance (May 30, 2024) | ||
12-101083684-A-T | not specified | Uncertain significance (Aug 20, 2023) | ||
12-101083688-G-A | not specified | Uncertain significance (Apr 22, 2024) | ||
12-101083723-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
12-101083778-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
12-101083792-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
12-101083811-T-G | not specified | Uncertain significance (Nov 30, 2022) | ||
12-101086703-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
12-101086705-G-A | Generalized epilepsy with febrile seizures plus | Pathogenic (Mar 26, 2024) | ||
12-101086797-C-A | Early infantile epileptic encephalopathy with suppression bursts | Pathogenic (Mar 26, 2024) | ||
12-101086807-A-T | Early infantile epileptic encephalopathy with suppression bursts | Pathogenic (Mar 26, 2024) | ||
12-101086811-T-A | Early infantile epileptic encephalopathy with suppression bursts | Pathogenic (Mar 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ANO4 | protein_coding | protein_coding | ENST00000392979 | 25 | 411116 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000322 | 1.00 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.53 | 344 | 504 | 0.682 | 0.0000266 | 6070 |
Missense in Polyphen | 157 | 230.72 | 0.68049 | 2741 | ||
Synonymous | 2.04 | 141 | 175 | 0.804 | 0.00000930 | 1648 |
Loss of Function | 5.20 | 19 | 63.8 | 0.298 | 0.00000369 | 695 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000764 | 0.000763 |
Ashkenazi Jewish | 0.000106 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000196 | 0.000193 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000692 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Has calcium-dependent phospholipid scramblase activity; scrambles phosphatidylserine, phosphatidylcholine and galactosylceramide. Does not exhibit calcium-activated chloride channel (CaCC) activity. {ECO:0000250|UniProtKB:Q8C5H1}.;
- Pathway
- Stimuli-sensing channels;Ion channel transport;Transport of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.811
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.97
Haploinsufficiency Scores
- pHI
- 0.339
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.584
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0483
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ano4
- Phenotype
Gene ontology
- Biological process
- chloride transport;ion transmembrane transport;calcium activated phosphatidylserine scrambling;calcium activated phosphatidylcholine scrambling;calcium activated galactosylceramide scrambling
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- intracellular calcium activated chloride channel activity;phospholipid scramblase activity;protein dimerization activity